1. Home
  2. ACLX vs TENB Comparison

ACLX vs TENB Comparison

Compare ACLX & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACLX
  • TENB
  • Stock Information
  • Founded
  • ACLX 2015
  • TENB 2002
  • Country
  • ACLX United States
  • TENB United States
  • Employees
  • ACLX N/A
  • TENB N/A
  • Industry
  • ACLX Biotechnology: Pharmaceutical Preparations
  • TENB Computer Software: Prepackaged Software
  • Sector
  • ACLX Health Care
  • TENB Technology
  • Exchange
  • ACLX Nasdaq
  • TENB Nasdaq
  • Market Cap
  • ACLX 4.1B
  • TENB 4.1B
  • IPO Year
  • ACLX 2022
  • TENB 2018
  • Fundamental
  • Price
  • ACLX $71.28
  • TENB $30.68
  • Analyst Decision
  • ACLX Strong Buy
  • TENB Buy
  • Analyst Count
  • ACLX 14
  • TENB 17
  • Target Price
  • ACLX $114.75
  • TENB $41.06
  • AVG Volume (30 Days)
  • ACLX 522.3K
  • TENB 1.6M
  • Earning Date
  • ACLX 08-07-2025
  • TENB 07-30-2025
  • Dividend Yield
  • ACLX N/A
  • TENB N/A
  • EPS Growth
  • ACLX N/A
  • TENB N/A
  • EPS
  • ACLX N/A
  • TENB N/A
  • Revenue
  • ACLX $56,979,000.00
  • TENB $949,251,000.00
  • Revenue This Year
  • ACLX N/A
  • TENB $11.66
  • Revenue Next Year
  • ACLX $108.81
  • TENB $7.86
  • P/E Ratio
  • ACLX N/A
  • TENB N/A
  • Revenue Growth
  • ACLX N/A
  • TENB 11.41
  • 52 Week Low
  • ACLX $47.86
  • TENB $28.51
  • 52 Week High
  • ACLX $107.37
  • TENB $45.45
  • Technical
  • Relative Strength Index (RSI)
  • ACLX 52.20
  • TENB 48.25
  • Support Level
  • ACLX $69.00
  • TENB $29.80
  • Resistance Level
  • ACLX $74.74
  • TENB $30.89
  • Average True Range (ATR)
  • ACLX 3.47
  • TENB 0.94
  • MACD
  • ACLX -0.19
  • TENB 0.16
  • Stochastic Oscillator
  • ACLX 56.94
  • TENB 72.58

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

About TENB Tenable Holdings Inc.

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

Share on Social Networks: